Skip to content

The effect of acupressure on stress, fasting blood suger and HbA1C in type II diabetes patients

The effect of acupressure on stress, fasting blood suger and HbA1C in type II diabetes patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200831048572N1
Enrollment
66
Registered
2020-09-23
Start date
2020-01-18
Completion date
Unknown
Last updated
2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Diabetes mellitus

Interventions

Intervention group: Participants in the present study will be type 2 diabetics.33 Participants will be included in the intervention group. Participants will press LR2 and LI4 acupressure areas. The in

Sponsors

Birjand University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Type 2 diabetes (according to the doctor's diagnosis) At least 6 months have passed since the diagnosis of diabetes Having a record in a diabetes clinic No insulin dependence Age 20 to 60 years No lower limb amputation No history of psychotic mental illness with self-reported patient Non-addiction to narcotics, stimulants and tobacco by the patient's own statement No allergies, sores or skin lesions in acupressure points No pregnancy no hemodialysis No neuropathy in acupressure points (based on doctor's approval) Similarity in terms of the drug used in diabetes

Exclusion criteria

Exclusion criteria: Having any severe and acute illness and its complications Dissatisfaction for any possible reason to continue the intervention

Design outcomes

Primary

MeasureTime frame
Stress levels. Timepoint: Before and one day after the intervention. Method of measurement: Stress score from the criteria of depression, anxiety and stress.;Fasting blood sugar. Timepoint: Before and one day after the intervention. Method of measurement: Bionic Kit.;Glycosylated hemoglobin. Timepoint: Before and three months after the start of the intervention. Method of measurement: Bionic Kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Yavari

Birjand University of Medical Sciences

z.yavari90@gmail.com+98 56 3238 1400

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026